RENOIR ITN is the European Network that aims to train PhD students in the field of Muscle Regeneration and Aging.
Liam Colley, research fellow in HMGBiotech, gave a speech about “Drugging the HMGB1-CXCL12-CXCR4 axis to promote Immunogenic Surrender”, highlighting how this axis plays a crucial role in promoting immunogenic surrender.
Therapeutic strategies targeting this axis include direct inhibition of HMGB1, CXCL12 blockade, CXCR4 antagonists, and combination therapies with immune checkpoint inhibitors. Further research is needed to fully understand the potential benefits and challenges associated with targeting the HMGB1-CXCL12-CXCR4 axis.
HMGBiotech can assist you and provide all the necessary information to help you make an informed decision for your research purposes concerning HMGB1.
